Cognitive Behavioral Therapy for Fear of Recurrence
What You Need to Know Before You Apply
What is the purpose of this trial?
The study includes participants experiencing distress with regard to stopping immunotherapy and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and anxiety and improve quality of life.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
Is Cognitive Behavioral Therapy safe for humans?
Cognitive Behavioral Therapy (CBT) and its variations like Mindfulness-Based Cognitive Therapy (MBCT) and Dialectical Behavior Therapy (DBT) are generally considered safe for humans. They are evidence-based treatments used for various conditions, including depression and borderline personality disorder, and have been shown to be effective without significant safety concerns.12345
How is Cognitive Behavioral Therapy unique for treating fear of cancer recurrence?
Cognitive Behavioral Therapy (CBT) for fear of cancer recurrence is unique because it can be delivered both online and face-to-face, making it more accessible. Additionally, it incorporates mindfulness techniques to help manage health anxiety, which is not commonly included in other treatments for this condition.678910
What data supports the effectiveness of this treatment for fear of recurrence?
Research shows that cognitive behavioral therapy (CBT) can effectively reduce fear of cancer recurrence (FCR) in cancer survivors, as seen in a case study where a breast cancer survivor experienced a significant decrease in FCR severity after CBT sessions. Additionally, mindfulness-based cognitive therapy (MBCT) has been shown to reduce health anxiety, which is related to FCR, suggesting its potential usefulness for this condition.16111213
Who Is on the Research Team?
Jason Luke, MD
Principal Investigator
Hillman Cancer Center
Are You a Good Fit for This Trial?
This trial is for English-speaking adults aged 21 or older who have been treated with immunotherapy for cancer and are now dealing with distress about stopping the treatment. It's not suitable for individuals experiencing delusions, hallucinations, or active thoughts of suicide.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive cognitive-behavioral therapy via telemedicine to reduce distress associated with stopping immunotherapy
Follow-up
Participants are monitored for changes in fear of recurrence, quality of life, anxiety, and depressive symptoms
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive Behavioral Therapy
Cognitive Behavioral Therapy is already approved in European Union, United States, Canada for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor